Literature DB >> 3566730

Retinol-binding protein in human serum: conformational changes induced by retinoic acid binding.

G Siegenthaler, J H Saurat.   

Abstract

Polyacrylamide gel electrophoresis and isoelectrofocusing followed by immunoblotting technique with an anti-human retinol-binding protein (RBP) serum were used to study holo-RBP and apo-RBP in human plasma. Three observations were made the technique allowed for the first time to directly and quantitatively analyse holo- and apo-RBP. Holo-RBP represented 97.86 +/- 0.78% and apo-RBP 1.94 +/- 0.73% of the total RBP. All-trans-retinoic acid (RA) was found to bind to apo-RBP and to significantly modify the tertiary structure of the protein; this raises the question of RBP involvement in the transport of RA. reconstitution of holo-RBP using apo-RBP from delipidized serum was achieved only after its incubation with natural all-trans-retinoids such as retinol, 3-dehydroretinol and retinoic acid but not with synthetic analogs of retinoic acid (13-cis-retinoic acid, TMMP, 13-cis-TMMP, TTNPB). It appears that RBP has a structure specificity for natural retinoids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3566730     DOI: 10.1016/0006-291x(87)91370-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Increased unbound retinol-binding protein 4 concentration induces apoptosis through receptor-mediated signaling.

Authors:  Chao-Hung Chen; Tusty-Jiuan Hsieh; Kun-Der Lin; Hsing-Yi Lin; Mei-Yueh Lee; Wei-Wen Hung; Pi-Jung Hsiao; Shyi-Jang Shin
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Expression of CRABP-I and -II in human epidermal cells. Alteration of relative protein amounts is linked to the state of differentiation.

Authors:  G Siegenthaler; I Tomatis; D Chatellard-Gruaz; S Jaconi; U Eriksson; J H Saurat
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

3.  Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver.

Authors:  Simone K Frey; Britta Nagl; Andrea Henze; Jens Raila; Beate Schlosser; Thomas Berg; Martin Tepel; Walter Zidek; Martin O Weickert; Andreas F H Pfeiffer; Florian J Schweigert
Journal:  Lipids Health Dis       Date:  2008-08-27       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.